Dublin, Oct. 10, 2022 (GLOBE NEWSWIRE) -- The "Cord Blood Banking Services Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

The global cord blood banking services market reached a value of US$ 1.48 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 2.83 Billion by 2027, exhibiting a CAGR of 11.41% during 2021-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Cord blood banking is a procedure of collecting and storing life-saving stem cells from the umbilical cord and placenta for future use. It uses hematopoietic stem cells that are present in the cord blood of the baby to develop it into red blood cells (RBCs), white blood cells (WBCs) and platelets.

It aids in the treatment of cancer, blood diseases and immune system disorders as cord blood banking is less complicated, painful and risky for the donor compared to the collection of stem cells from bone marrow. As a result, it finds extensive applications in hospitals, research institutes, and specialty clinics.

Cord Blood Banking Services Market Trends:

The growing prevalence of different cancers, such as lymphoma and leukemia, due to longer working hours, stressful lives, and excessive smoking and alcohol consumption represents one of the key factors driving the market. Moreover, there is an increase in the utilization of cord blood banking services for the treatment of immunodeficiency disorders across the globe.

This, coupled with the increasing awareness among individuals about the benefits and wide availability of cord blood banking service providers, is propelling the growth of the market. In addition, governments of several countries are extensively investing in research and development (R&D) activities to facilitate clinical trials of cord blood stem cells.

In line with this, the growing number of patients with damaged bone marrow worldwide is positively influencing the market. Besides this, the rising diagnostic screening of cord blood in private centers as per guidelines and regulations of regulatory authorities is offering lucrative growth opportunities to industry investors. Additionally, the expanding healthcare industry is strengthening the growth of the market.

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Alphacord LLC, Americord Registry LLC, ATCC, California Cryobank, Cordlife Group LImited, Cryo-Cell International Inc., Global Cord Blood Corporation, LifeBank, LifeCell International Pvt. Ltd., National Cord Blood Program, Norton Healthcare Inc., Perkinelmer Inc. and StemCyte India Therapeutics Pvt. Ltd.

Key Questions Answered in This Report:

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction4.1 Overview4.2 Key Industry Trends

5 Global Cord Blood Banking Services Market5.1 Market Overview5.2 Market Performance5.3 Impact of COVID-195.4 Market Forecast

6 Market Breakup by Component6.1 Cord Blood6.1.1 Market Trends6.1.2 Market Forecast6.2 Cord Tissue6.2.1 Market Trends6.2.2 Market Forecast

7 Market Breakup by Storage Services7.1 Public Cord Blood Banks7.1.1 Market Trends7.1.2 Market Forecast7.2 Private Cord Blood Banks7.2.1 Market Trends7.2.2 Market Forecast

8 Market Breakup by Application8.1 Cancer Disease8.1.1 Market Trends8.1.2 Market Forecast8.2 Diabetes8.2.1 Market Trends8.2.2 Market Forecast8.3 Blood Disease8.3.1 Market Trends8.3.2 Market Forecast8.4 Immune Disorders8.4.1 Market Trends8.4.2 Market Forecast8.5 Metabolic Disorders8.5.1 Market Trends8.5.2 Market Forecast8.6 Others8.6.1 Market Trends8.6.2 Market Forecast

9 Market Breakup by Region

10 SWOT Analysis

11 Value Chain Analysis

12 Porters Five Forces Analysis

13 Price Analysis

14 Competitive Landscape14.1 Market Structure14.2 Key Players14.3 Profiles of Key Players14.3.1 Alphacord LLC14.3.1.1 Company Overview14.3.1.2 Product Portfolio14.3.2 Americord Registry LLC14.3.2.1 Company Overview14.3.2.2 Product Portfolio14.3.3 ATCC14.3.3.1 Company Overview14.3.3.2 Product Portfolio14.3.4 California Cryobank14.3.4.1 Company Overview14.3.4.2 Product Portfolio14.3.5 Cordlife Group LImited14.3.5.1 Company Overview14.3.5.2 Product Portfolio14.3.5.3 Financials14.3.6 Cryo-Cell International Inc.14.3.6.1 Company Overview14.3.6.2 Product Portfolio14.3.6.3 Financials14.3.7 Global Cord Blood Corporation14.3.7.1 Company Overview14.3.7.2 Product Portfolio14.3.8 LifeBank14.3.8.1 Company Overview14.3.8.2 Product Portfolio14.3.9 LifeCell International Pvt. Ltd.14.3.9.1 Company Overview14.3.9.2 Product Portfolio14.3.10 National Cord Blood Program14.3.10.1 Company Overview14.3.10.2 Product Portfolio14.3.11 Norton Healthcare Inc.14.3.11.1 Company Overview14.3.11.2 Product Portfolio14.3.12 Perkinelmer Inc.14.3.12.1 Company Overview14.3.12.2 Product Portfolio14.3.12.3 Financials14.3.12.4 SWOT Analysis14.3.13 StemCyte India Therapeutics Pvt. Ltd.14.3.13.1 Company Overview14.3.13.2 Product Portfolio

For more information about this report visit https://www.researchandmarkets.com/r/iz14xq

See more here:

Outlook on the Cord Blood Banking Services Global Market to 2027 - by Component, Storage Services, Application and Region - GlobeNewswire

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh